Home › Burkitt Lymphoma › Rhode Island

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Rhode Island

7 pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa mga site sa Rhode Island.

Mga Lungsod sa Rhode Island

Providence7 pag-aaral

Opisyal na teksto ng pag-aaral (English)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Rhode Island Hospital, Providence

Nagre-recruitPhase 2

366 Days – 46 Years · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Rhode Island Hospital, Providence

Nagre-recruitPhase 3

Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03150693

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Rhode Island Hospital, Providence

Nagre-recruitPhase 2

365 Days · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06317662

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Lifespan Cancer Institute at Rhode Island Hospital, Providence

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Rhode Island Hospital, Providence

Nagre-recruitPhase 2

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Rhode Island Hospital, Providence

Nagre-recruitPhase 3

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

Rhode Island Hospital, Providence

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.